Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:activities |
anti-inflammatory
bronchodilation |
| gptkbp:appointed_by |
gptkb:superhero
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:class |
gptkb:physicist
long-acting beta-agonist |
| gptkbp:clinical_trial |
studies on efficacy
studies on safety |
| gptkbp:contains |
fluticasone propionate
salmeterol |
| gptkbp:contraindication |
hypersensitivity to components
severe asthma attacks |
| gptkbp:dosage_form |
aerosol
inhalation powder |
| gptkbp:formulation |
metered-dose inhaler
diskus |
| https://www.w3.org/2000/01/rdf-schema#label |
Seretide
|
| gptkbp:indication |
maintenance treatment
|
| gptkbp:ingredients |
fluticasone
salmeterol xinafoate |
| gptkbp:interacts_with |
MAO inhibitors
diuretics beta-blockers other bronchodilators |
| gptkbp:is_available_in |
gptkb:various_countries
|
| gptkbp:is_used_for |
gptkb:asthma
chronic obstructive pulmonary disease |
| gptkbp:manufacturer |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:marketed_as |
gptkb:Advair
Seretide Accuhaler Seretide Diskus |
| gptkbp:packaging |
blister pack
aerosol canister |
| gptkbp:population |
read before use
|
| gptkbp:provides_information_on |
recommended for COPD
recommended for chronic asthma |
| gptkbp:requires |
prescription only
|
| gptkbp:research |
ongoing studies
long-term effects comparative effectiveness |
| gptkbp:safety_features |
monitor for side effects
not for acute attacks |
| gptkbp:shelf_life |
check regularly
|
| gptkbp:side_effect |
headache
palpitations muscle cramps hoarseness thrush |
| gptkbp:storage |
room temperature
protect from moisture |
| gptkbp:type_of_care |
important for effectiveness
|